Wikipedia:WikiProject Medicine/Cochrane/Cochrane Review List/Cancer

  Cochrane Cancer Network: Reviews to be considered for Wikipedia Cochrane Review Lists updated: July 6 2020

Breast Cancer Group
Updated: Aug 1 2023


 * ✅ 2023-6 Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes PMID undefined https://doi.org/10.1002/14651858.CD014463.pub2

2023-4 Training health workers in clinical breast examination for early detection of breast cancer in low- and middle-income countries PMID 37070783 https://doi.org/10.1002/14651858.CD012515.pub2

✅ 2023-3 Skin-sparing mastectomy for the treatment of breast cancer PMID 36972145 https://doi.org/10.1002/14651858.CD010993.pub2

2023-3 Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk PMID 36999589 https://doi.org/10.1002/14651858.CD009632.pub3

2022-1 Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer PMID undefined https://doi.org/10.1002/14651858.CD013167.pub2

2021-11 Perioperative systemic nonsteroidal anti-inflammatory drugs (NSAIDs) in women undergoing breast surgery PMID undefined https://doi.org/10.1002/14651858.CD013290.pub2


 * ✅ 2021-10 Oncoplastic breast-conserving surgery for women with primary breast cancer PMID undefined https://doi.org/10.1002/14651858.CD013658.pub2

2021-10 Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review PMID undefined https://doi.org/10.1002/14651858.CD013091.pub2

2021-5 Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer PMID undefined https://doi.org/10.1002/14651858.CD011220.pub2

2021-4 PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer PMID undefined https://doi.org/10.1002/14651858.CD011395.pub2

2021-2 Paravertebral anaesthesia with or without sedation versus general anaesthesia for women undergoing breast cancer surgery PMID undefined https://doi.org/10.1002/14651858.CD012968.pub2

2021-2 Specialist breast care nurses for support of women with breast cancer PMID undefined https://doi.org/10.1002/14651858.CD005634.pub3

2020-12 Body weight management in overweight and obese breast cancer survivors PMID undefined https://doi.org/10.1002/14651858.CD012110.pub2

2020-10 Platinum-containing regimens for triple-negative metastatic breast cancer PMID undefined https://doi.org/10.1002/14651858.CD013750

✅ 2020-4 Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast reconstruction PMID undefined https://doi.org/10.1002/14651858.CD013280.pub2

2020-3 Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer PMID undefined https://doi.org/10.1002/14651858.CD013538

2020-1 Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer PMID undefined https://doi.org/10.1002/14651858.CD012988.pub2

2019-3 Mindfulness-based stress reduction for women diagnosed with breast cancer PMID 30916356 https://doi.org/10.1002/14651858.CD011518.pub2

2019-2 Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment PMID 30779124 https://doi.org/10.1002/14651858.CD011433.pub2

2019-2 Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer PMID 30776132 https://doi.org/10.1002/14651858.CD012873.pub2

2017-11 Tumour bed boost radiotherapy for women after breast-conserving surgery PMID 29105051 https://doi.org/10.1002/14651858.CD011987.pub2

2017-3 Online support groups for women with breast cancer PMID 28278559 https://doi.org/10.1002/14651858.CD011652.pub2

2016-11 Nipple- and areola-sparing mastectomy for the treatment of breast cancer PMID 27898991 https://doi.org/10.1002/14651858.CD008932.pub3

2016-7 Fraction size in radiation therapy for breast conservation in early breast cancer PMID 27425588 https://doi.org/10.1002/14651858.CD003860.pub4

2016-5 High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer PMID 27200512 https://doi.org/10.1002/14651858.CD003139.pub3

2015-12 Localization techniques for guided surgical excision of non-palpable breast lesions PMID 26718728 https://doi.org/10.1002/14651858.CD009206.pub2

2015-2 Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy PMID 25677413 https://doi.org/10.1002/14651858.CD009765.pub2

2014-5 Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus) PMID 35658165 https://doi.org/10.1002/14651858.CD004272.pub3

2013-10 Wound drainage after axillary dissection for carcinoma of the breast PMID 24158902 https://doi.org/10.1002/14651858.CD006823.pub2

2013-5 Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery PMID 23728694 https://doi.org/10.1002/14651858.CD009557.pub2

2013-4 Sequencing of chemotherapy and radiotherapy for early breast cancer PMID 23633328 https://doi.org/10.1002/14651858.CD005212.pub3

2012-10 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients PMID 23076939 https://doi.org/10.1002/14651858.CD007913.pub2

2012-7 Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer PMID 22786517 https://doi.org/10.1002/14651858.CD008941.pub2

2012-2 Cancer genetic risk assessment for individuals at risk of familial breast cancer PMID 22336791 https://doi.org/10.1002/14651858.CD003721.pub3

2011-7 Immediate versus delayed reconstruction following surgery for breast cancer PMID 21735435 https://doi.org/10.1002/14651858.CD008674.pub2

2011-5 Timing of breast surgery in premenopausal breast cancer patients PMID 21563138 https://doi.org/10.1002/14651858.CD003720.pub2

Childhood Cancer Group
Updated Aug 1 2023

2023-5 PEG-asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta-analysis PMID undefined https://doi.org/10.1002/14651858.CD014570.pub2

2021-11 Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma PMID undefined https://doi.org/10.1002/14651858.CD012325.pub2

2021-9 High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma PMID undefined https://doi.org/10.1002/14651858.CD011405.pub2

2021-9 High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma PMID undefined https://doi.org/10.1002/14651858.CD011406.pub2

2021-8 Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer PMID undefined https://doi.org/10.1002/14651858.CD012924.pub2

2020-3 Severe fatigue after treatment for childhood cancer PMID undefined https://doi.org/10.1002/14651858.CD012681.pub2

2019-4 Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation PMID 31016728 https://doi.org/10.1002/14651858.CD012442.pub2

2017-11 Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia PMID 29106702 https://doi.org/10.1002/14651858.CD008727.pub4

2017-8 Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation PMID 28840597 https://doi.org/10.1002/14651858.CD010685.pub3

2017-4 Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma PMID 28429876 https://doi.org/10.1002/14651858.CD010349.pub2

2016-11 Interventions for promoting participation in shared decision-making for children with cancer PMID 27898175 https://doi.org/10.1002/14651858.CD008970.pub3

2016-8 Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer PMID 27552363 https://doi.org/10.1002/14651858.CD008011.pub3

2016-6 Radiotherapy for diffuse brainstem glioma in children and young adults PMID 27378212 https://doi.org/10.1002/14651858.CD010439.pub2

2016-4 Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia PMID 27107610 https://doi.org/10.1002/14651858.CD006247.pub3

2016-2 Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia PMID 26899263 https://doi.org/10.1002/14651858.CD008382.pub2

2015-5 Rapid COJEC versus standard induction therapies for high-risk neuroblastoma PMID 25989478 https://doi.org/10.1002/14651858.CD010774.pub2

2015-1 Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children PMID 25560834 https://doi.org/10.1002/14651858.CD008403.pub3

2014-9 Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer PMID 25188452 https://doi.org/10.1002/14651858.CD006647.pub4

2013-9 Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters PMID 24026801 https://doi.org/10.1002/14651858.CD009160.pub2

2013-8 Influenza vaccination in children being treated with chemotherapy for cancer PMID 23904194 https://doi.org/10.1002/14651858.CD006484.pub3

2013-6 Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer PMID 23799867 https://doi.org/10.1002/14651858.CD008975.pub2

2011-5 Methotrexate for high-grade osteosarcoma in children and young adults PMID 21563152 https://doi.org/10.1002/14651858.CD006325.pub3

Gynaecological, Neuro-oncology and Orphan Cancer Group
Updated: Aug 1 2023

2023-3 Antidepressants for the treatment of depression in people with cancer PMID 36999619 https://doi.org/10.1002/14651858.CD011006.pub4

2023-3 Exercise interventions for adults with cancer receiving radiation therapy alone PMID 36912791 https://doi.org/10.1002/14651858.CD013448.pub2

2022-11 Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation PMID 36427235 https://doi.org/10.1002/14651858.CD011335.pub3

2022-11 Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer PMID 36440894 https://doi.org/10.1002/14651858.CD013604.pub2

2022-9 Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines PMID 36162822 https://doi.org/10.1002/14651858.CD014638.pub2

2022-9 Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery PMID 36161421 https://doi.org/10.1002/14651858.CD015048.pub2

2022-9 Interventions for the management of fatigue in adults with a primary brain tumour PMID 36094728 https://doi.org/10.1002/14651858.CD011376.pub3

2022-9 Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer PMID 36111784 https://doi.org/10.1002/14651858.CD012246.pub2

2022-8 Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer PMID 36041232 https://doi.org/10.1002/14651858.CD007697.pub3

2022-8 Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer PMID 35994243 https://doi.org/10.1002/14651858.CD010260.pub3

2022-7 Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer PMID 35866378 https://doi.org/10.1002/14651858.CD008766.pub3

2022-7 Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women PMID 35879201 https://doi.org/10.1002/14651858.CD011964.pub2

2022-3 Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma PMID undefined https://doi.org/10.1002/14651858.CD013387.pub2

2022-2 Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer PMID undefined https://doi.org/10.1002/14651858.CD012007.pub2

2022-1 Early palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers PMID undefined https://doi.org/10.1002/14651858.CD013440.pub2

2021-11 Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis PMID undefined https://doi.org/10.1002/14651858.CD013700.pub2

2021-9 Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents PMID undefined https://doi.org/10.1002/14651858.CD014739

2021-7 Protons versus photons for the treatment of chordoma PMID undefined https://doi.org/10.1002/14651858.CD013224.pub2

2021-7 Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer PMID undefined https://doi.org/10.1002/14651858.CD005343.pub6

2021-6 Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer PMID undefined https://doi.org/10.1002/14651858.CD013021.pub2

2021-3 Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer PMID undefined https://doi.org/10.1002/14651858.CD013348.pub2

2021-3 Prognostic value of test(s) for O6-methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide PMID undefined https://doi.org/10.1002/14651858.CD013316.pub2

2021-1 Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early-stage cervical cancer PMID undefined https://doi.org/10.1002/14651858.CD012863.pub2

2021-1 Treatment options for progression or recurrence of glioblastoma: a network meta-analysis PMID undefined https://doi.org/10.1002/14651858.CD013579.pub2

2021-1 Intraoperative imaging technology to maximise extent of resection for glioma: a network meta-analysis PMID undefined https://doi.org/10.1002/14651858.CD013630.pub2

2020-9 Interventions to reduce the time to diagnosis of brain tumours PMID undefined https://doi.org/10.1002/14651858.CD013564.pub2

2020-7 (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people PMID undefined https://doi.org/10.1002/14651858.CD009833.pub2

2020-6 Telephone interventions for symptom management in adults with cancer PMID undefined https://doi.org/10.1002/14651858.CD007568.pub2

2020-5 Anti-epidermal growth factor receptor therapy for glioblastoma in adults PMID undefined https://doi.org/10.1002/14651858.CD013238.pub2

2020-3 Health education interventions to promote early presentation and referral for women with symptoms of endometrial cancer PMID undefined https://doi.org/10.1002/14651858.CD013253.pub2

2020-1 Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas PMID undefined https://doi.org/10.1002/14651858.CD009229.pub3

2019-12 Management of drainage for malignant ascites in gynaecological cancer PMID 31825525 https://doi.org/10.1002/14651858.CD007794.pub3

2019-12 Interval brain imaging for adults with cerebral glioma PMID 31873964 https://doi.org/10.1002/14651858.CD013137.pub2

2019-11 Dietary interventions for adult cancer survivors PMID 31755089 https://doi.org/10.1002/14651858.CD011287.pub2

2019-11 Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males PMID 31755549 https://doi.org/10.1002/14651858.CD013479

2019-7 Interventions to help support caregivers of people with a brain or spinal cord tumour PMID 31264707 https://doi.org/10.1002/14651858.CD012582.pub2

2019-6 Interventions for the treatment of Paget's disease of the vulva PMID 31167037 https://doi.org/10.1002/14651858.CD009245.pub3

2019-3 Systematic screening and assessment of psychosocial well-being and care needs of people with cancer PMID 30909317 https://doi.org/10.1002/14651858.CD012387.pub2

2019-3 Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones PMID 30845364 https://doi.org/10.1002/14651858.CD010778.pub2

2019-3 Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer PMID 30907434 https://doi.org/10.1002/14651858.CD009786.pub3

2019-2 Nerve-sparing radical hysterectomy compared to standard radical hysterectomy for women with early stage cervical cancer (stage Ia2 to IIa) PMID 30746689 https://doi.org/10.1002/14651858.CD012828.pub2

2019-1 Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer PMID 30605229 https://doi.org/10.1002/14651858.CD012184.pub2

2018-12 Exercise interventions for people undergoing multimodal cancer treatment that includes surgery PMID 30536366 https://doi.org/10.1002/14651858.CD012280.pub2

2018-11 Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer PMID 30480754 https://doi.org/10.1002/14651858.CD010559.pub2

2018-10 Extended-field radiotherapy for locally advanced cervical cancer PMID 30362204 https://doi.org/10.1002/14651858.CD012301.pub2

2018-10 Epidermal growth factor receptor blockers for the treatment of ovarian cancer PMID 30321910 https://doi.org/10.1002/14651858.CD007927.pub4

2018-9 Interventions for promoting habitual exercise in people living with and beyond cancer PMID 30229557 https://doi.org/10.1002/14651858.CD010192.pub3

2018-8 Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations PMID 30141832 https://doi.org/10.1002/14651858.CD012464.pub2

2018-8 Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis PMID 30125049 https://doi.org/10.1002/14651858.CD012086.pub2

2018-7 Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery PMID 29987845 https://doi.org/10.1002/14651858.CD011492.pub2

2018-7 Communication skills training for healthcare professionals working with people who have cancer PMID 30039853 https://doi.org/10.1002/14651858.CD003751.pub4

2018-5 Hormone replacement therapy for women previously treated for endometrial cancer PMID 29763969 https://doi.org/10.1002/14651858.CD008830.pub3

2018-4 Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults PMID 29683475 https://doi.org/10.1002/14651858.CD010604.pub2

2018-2 Influenza vaccines in immunosuppressed adults with cancer PMID 29388675 https://doi.org/10.1002/14651858.CD008983.pub3

2018-2 Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia PMID 29431861 https://doi.org/10.1002/14651858.CD004121.pub4

2018-1 Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers PMID 29360138 https://doi.org/10.1002/14651858.CD012529.pub2

2018-1 Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation PMID 29357120 https://doi.org/10.1002/14651858.CD011551.pub2

2018-1 Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases PMID 29365347 https://doi.org/10.1002/14651858.CD003869.pub4

2017-9 Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases PMID 28945270 https://doi.org/10.1002/14651858.CD006121.pub4

2017-6 Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies PMID 28660687 https://doi.org/10.1002/14651858.CD007387.pub4

2017-6 Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer PMID 28577308 https://doi.org/10.1002/14651858.CD003914.pub4

2017-3 Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility PMID 28349511 https://doi.org/10.1002/14651858.CD010931.pub2

2017-1 Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test PMID 28125861 https://doi.org/10.1002/14651858.CD009836.pub2

2016-8 Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment PMID 27529826 https://doi.org/10.1002/14651858.CD011325.pub2

2016-6 Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer PMID 27356090 https://doi.org/10.1002/14651858.CD011322.pub2

2016-3 Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy PMID 26938118 https://doi.org/10.1002/14651858.CD005008.pub4

2016-1 Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer PMID 26801659 https://doi.org/10.1002/14651858.CD011732.pub2

2016-1 Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia PMID 26760424 https://doi.org/10.1002/14651858.CD008891.pub3

2016-1 Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia PMID 26728940 https://doi.org/10.1002/14651858.CD011837.pub2

2016-1 Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer PMID 26755441 https://doi.org/10.1002/14651858.CD005340.pub4

2015-8 Medical interventions for high-grade vulval intraepithelial neoplasia PMID 26284429 https://doi.org/10.1002/14651858.CD007924.pub3

2014-10 Colony-stimulating factors for chemotherapy-induced febrile neutropenia PMID 25356786 https://doi.org/10.1002/14651858.CD003039.pub2

2014-9 Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment PMID 25198378 https://doi.org/10.1002/14651858.CD006119.pub3

2014-9 Routine versus selective antifungal administration for control of fungal infections in patients with cancer PMID 25188768 https://doi.org/10.1002/14651858.CD000026.pub2

2014-4 Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent) PMID 24753008 https://doi.org/10.1002/14651858.CD006912.pub2

2014-3 Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases PMID 24585087 https://doi.org/10.1002/14651858.CD009454.pub2

2014-3 Surgical interventions for high-grade vulval intraepithelial neoplasia PMID 24596022 https://doi.org/10.1002/14651858.CD007928.pub3

2014-2 Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia PMID 24563222 https://doi.org/10.1002/14651858.CD004707.pub3

2014-1 Image guided surgery for the resection of brain tumours PMID 24474579 https://doi.org/10.1002/14651858.CD009685.pub2

2013-12 Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia PMID 24302533 https://doi.org/10.1002/14651858.CD001421.pub3

2013-10 Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer PMID 24085528 https://doi.org/10.1002/14651858.CD006651.pub3

2013-8 Chemotherapy for thymic carcinoma and advanced thymoma in adults PMID 23970462 https://doi.org/10.1002/14651858.CD008588.pub2

2013-6 Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia PMID 23813455 https://doi.org/10.1002/14651858.CD003038.pub2

2013-6 Maintenance chemotherapy for ovarian cancer PMID 23813336 https://doi.org/10.1002/14651858.CD007414.pub3

2013-6 Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer PMID 23740789 https://doi.org/10.1002/14651858.CD009620.pub2

2013-3 Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions PMID 23543559 https://doi.org/10.1002/14651858.CD008054.pub2

2013-3 Multidimensional rehabilitation programmes for adult cancer survivors PMID 23543556 https://doi.org/10.1002/14651858.CD007730.pub2

2013-3 Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer PMID 23543561 https://doi.org/10.1002/14651858.CD008217.pub3

2013-2 Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma PMID 23450567 https://doi.org/10.1002/14651858.CD006246.pub2

2013-1 Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour PMID 23440800 https://doi.org/10.1002/14651858.CD005196.pub4

2012-12 Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer PMID 23235641 https://doi.org/10.1002/14651858.CD007406.pub3

2012-10 Chemotherapy for metastatic and recurrent cervical cancer PMID 23076924 https://doi.org/10.1002/14651858.CD006469.pub2

2012-7 Electric fans for reducing adverse health impacts in heatwaves PMID 22786530 https://doi.org/10.1002/14651858.CD009888.pub2

2011-5 Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma PMID 21563139 https://doi.org/10.1002/14651858.CD003911.pub2

2011-4 Interventions for encouraging sexual behaviours intended to prevent cervical cancer PMID 21491379 https://doi.org/10.1002/14651858.CD001035.pub2

2011-3 Chemotherapy wafers for high grade glioma PMID 21412902 https://doi.org/10.1002/14651858.CD007294.pub2

2011-3 Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease PMID 21412906 https://doi.org/10.1002/14651858.CD007584.pub2

2011-2 Thymic peptides for treatment of cancer patients PMID 21328265 https://doi.org/10.1002/14651858.CD003993.pub3

Haematology Group
Updated: Aug 1 2023

2023-7 Antiplatelet agents for the treatment of adults with COVID-19 PMID undefined https://doi.org/10.1002/14651858.CD015078

2023-6 Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults PMID undefined https://doi.org/10.1002/14651858.CD009159.pub3

2023-1 Remdesivir for the treatment of COVID-19 PMID 36695483 https://doi.org/10.1002/14651858.CD014962.pub2

2023-1 Hyperimmune immunoglobulin for people with COVID-19 PMID 36700518 https://doi.org/10.1002/14651858.CD015167.pub2

2022-9 Fluvoxamine for the treatment of COVID-19 PMID 36103313 https://doi.org/10.1002/14651858.CD015391

2022-8 Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review PMID 35943061 https://doi.org/10.1002/14651858.CD015021

2022-6 Janus kinase inhibitors for the treatment of COVID-19 PMID 35695334 https://doi.org/10.1002/14651858.CD015209

2022-6 Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis PMID 35724934 https://doi.org/10.1002/14651858.CD012633.pub2

2021-10 Colchicine for the treatment of COVID-19 PMID undefined https://doi.org/10.1002/14651858.CD015045

2021-9 Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma PMID undefined https://doi.org/10.1002/14651858.CD013365.pub2

2021-3 Disease-modifying treatments for primary autoimmune haemolytic anaemia PMID undefined https://doi.org/10.1002/14651858.CD012493.pub2

2020-10 Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia PMID undefined https://doi.org/10.1002/14651858.CD013399.pub2

2017-11 Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours PMID 29178132 https://doi.org/10.1002/14651858.CD012035.pub2

2017-9 Thrombopoietin mimetics for patients with myelodysplastic syndromes PMID 28962071 https://doi.org/10.1002/14651858.CD009883.pub2

2017-9 Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation PMID 28945930 https://doi.org/10.1002/14651858.CD012497.pub2

2017-9 Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis PMID 28901021 https://doi.org/10.1002/14651858.CD008814.pub2

2017-5 Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma PMID 28541603 https://doi.org/10.1002/14651858.CD007941.pub3

2016-10 Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review PMID 27797129 https://doi.org/10.1002/14651858.CD012055.pub2

2016-9 Plasma transfusions prior to insertion of central lines for people with abnormal coagulation PMID 27647489 https://doi.org/10.1002/14651858.CD011756.pub2

2016-8 Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation PMID 27548292 https://doi.org/10.1002/14651858.CD010982.pub2

2016-4 Bortezomib for the treatment of multiple myeloma PMID 27096326 https://doi.org/10.1002/14651858.CD010816.pub2

2016-2 Meditation for adults with haematological malignancies PMID 26840029 https://doi.org/10.1002/14651858.CD011157.pub2

2016-2 The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents PMID 26845108 https://doi.org/10.1002/14651858.CD009624.pub2

2016-2 Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes PMID 26880256 https://doi.org/10.1002/14651858.CD009310.pub2

2015-12 Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy PMID 26687844 https://doi.org/10.1002/14651858.CD007107.pub3

2015-11 Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission PMID 26544114 https://doi.org/10.1002/14651858.CD010248.pub2

2015-10 Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma PMID 26484982 https://doi.org/10.1002/14651858.CD010615.pub2

2015-6 The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia PMID 26037486 https://doi.org/10.1002/14651858.CD010432.pub2

2015-6 Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia PMID 26107113 https://doi.org/10.1002/14651858.CD008562.pub3

2015-5 Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation PMID 26017019 https://doi.org/10.1002/14651858.CD009311.pub2

2015-4 Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis PMID 25860512 https://doi.org/10.1002/14651858.CD010298.pub2

2015-1 Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma PMID 25572491 https://doi.org/10.1002/14651858.CD010533.pub2

2014-10 Deferasirox for managing iron overload in people with myelodysplastic syndrome PMID 25348770 https://doi.org/10.1002/14651858.CD007461.pub3

2014-7 Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation PMID 25061777 https://doi.org/10.1002/14651858.CD010280.pub2

2014-6 The role of additional radiotherapy for primary central nervous system lymphoma PMID 24931518 https://doi.org/10.1002/14651858.CD009211.pub2

2014-6 Yoga in addition to standard care for patients with haematological malignancies PMID 24919720 https://doi.org/10.1002/14651858.CD010146.pub2

2014-4 Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults PMID 24748537 https://doi.org/10.1002/14651858.CD010189.pub2

2013-8 Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma PMID 23986525 https://doi.org/10.1002/14651858.CD008908.pub3

2013-7 Anthracycline-containing regimens for treatment of follicular lymphoma in adults PMID 23832787 https://doi.org/10.1002/14651858.CD008909.pub2

2013-6 High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma PMID 23784872 https://doi.org/10.1002/14651858.CD009411.pub2

2013-4 Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia PMID 23633335 https://doi.org/10.1002/14651858.CD006503.pub3

2013-3 The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission PMID 23543579 https://doi.org/10.1002/14651858.CD009594.pub2

2012-12 Erythropoietin or darbepoetin for patients with cancer PMID 23235597 https://doi.org/10.1002/14651858.CD003407.pub5

2012-11 Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia PMID 23152253 https://doi.org/10.1002/14651858.CD008079.pub2

2012-11 Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL) PMID 23152274 https://doi.org/10.1002/14651858.CD009355.pub2

2012-10 First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies PMID 23076906 https://doi.org/10.1002/14651858.CD004626.pub3

2012-9 Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia PMID 22972131 https://doi.org/10.1002/14651858.CD009045.pub2

2012-6 Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia PMID 22696376 https://doi.org/10.1002/14651858.CD008238.pub3

2012-2 Alemtuzumab for patients with chronic lymphocytic leukaemia PMID 22336834 https://doi.org/10.1002/14651858.CD008078.pub2

2012-1 High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults PMID 22258971 https://doi.org/10.1002/14651858.CD007678.pub2

2011-10 Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission PMID 21975786 https://doi.org/10.1002/14651858.CD008818.pub2

2011-7 Therapeutic interventions for Burkitt lymphoma in children PMID 21735399 https://doi.org/10.1002/14651858.CD005198.pub3

2011-7 TPO receptor agonist for chronic idiopathic thrombocytopenic purpura PMID 21735426 https://doi.org/10.1002/14651858.CD008235.pub2

Lung Cancer Group
Updated: Aug 1 2023

2023-7 Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status PMID undefined https://doi.org/10.1002/14651858.CD013382.pub2

2022-8 Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality PMID 35921047 https://doi.org/10.1002/14651858.CD013829.pub2

2022-1 Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer PMID undefined https://doi.org/10.1002/14651858.CD013453.pub2

2021-12 Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent PMID undefined https://doi.org/10.1002/14651858.CD011300.pub3

2021-3 First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer PMID undefined https://doi.org/10.1002/14651858.CD010383.pub3

2019-6 Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer PMID 31204439 https://doi.org/10.1002/14651858.CD009955.pub3

2019-6 Interventions for smoking cessation in people diagnosed with lung cancer PMID 31173336 https://doi.org/10.1002/14651858.CD011751.pub3

2019-2 Exercise training for advanced lung cancer PMID 30741408 https://doi.org/10.1002/14651858.CD012685.pub2

2018-1 Gefitinib for advanced non-small cell lung cancer PMID 29336009 https://doi.org/10.1002/14651858.CD006847.pub2

2016-10 Postoperative radiotherapy for non-small cell lung cancer PMID 27727451 https://doi.org/10.1002/14651858.CD002142.pub4

2015-10 Chemotherapy for advanced non-small cell lung cancer in the elderly population PMID 26482542 https://doi.org/10.1002/14651858.CD010463.pub2

2015-8 Platinum versus non-platinum chemotherapy regimens for small cell lung cancer PMID 26233609 https://doi.org/10.1002/14651858.CD006849.pub3

2015-1 Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer PMID 25586198 https://doi.org/10.1002/14651858.CD002143.pub4

2014-11 PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer PMID 25393718 https://doi.org/10.1002/14651858.CD009519.pub2

2013-6 Screening for lung cancer PMID 23794187 https://doi.org/10.1002/14651858.CD001991.pub3

2012-12 Palliative endobronchial brachytherapy for non-small cell lung cancer PMID 23235606 https://doi.org/10.1002/14651858.CD004284.pub3

2011-9 Non-invasive interventions for improving well-being and quality of life in patients with lung cancer PMID 21901689 https://doi.org/10.1002/14651858.CD004282.pub3

Urology project information
'''
 * Update performed: Aug 1 2023 (contains reviews published in the past 10 years, flagged in the Cochrane Library as under Cochrane Urology)
 * Link to the updated list of Wikipedia articles to consider for Spanish Wikipedia
 * Link to the raw search results. Includes all reviews included ("True") and not included ("false") on English Wikipedia. This could be used for quality control checking of what is already shared on English Wikipedia. A list of reviews already shared on Spanish Wikipedia can also be prepared, on request.

Urology Group
Updated: Aug 1 2023

2023-7 Non-surgical therapies for Peyronie's disease PMID undefined https://doi.org/10.1002/14651858.CD012206.pub2

2023-7 Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones PMID undefined https://doi.org/10.1002/14651858.CD012607.pub2

2023-5 First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis PMID undefined https://doi.org/10.1002/14651858.CD013798.pub2

2023-3 Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer PMID 36884035 https://doi.org/10.1002/14651858.CD012817.pub2

2022-4 Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer PMID undefined https://doi.org/10.1002/14651858.CD014887.pub2

2021-12 Blue versus white light for transurethral resection of non-muscle invasive bladder cancer PMID undefined https://doi.org/10.1002/14651858.CD013776.pub2

2021-8 Posterior musculofascial reconstruction in robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer PMID undefined https://doi.org/10.1002/14651858.CD013677.pub2

2021-8 Degarelix for treating advanced hormone-sensitive prostate cancer PMID undefined https://doi.org/10.1002/14651858.CD012548.pub2

2021-7 Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis PMID undefined https://doi.org/10.1002/14651858.CD013656.pub2

2021-6 Intravesical gemcitabine for non-muscle invasive bladder cancer PMID undefined https://doi.org/10.1002/14651858.CD009294.pub3

2021-3 Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions PMID undefined https://doi.org/10.1002/14651858.CD012250.pub2

2021-3 Selective serotonin re-uptake inhibitors for premature ejaculation in adult men PMID undefined https://doi.org/10.1002/14651858.CD012799.pub2

2021-2 Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction PMID undefined https://doi.org/10.1002/14651858.CD012336.pub2

2020-2 Water for preventing urinary stones PMID undefined https://doi.org/10.1002/14651858.CD004292.pub4

2019-4 Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer PMID 31022301 https://doi.org/10.1002/14651858.CD012663.pub2

2017-12 Bisphosphonates for advanced prostate cancer PMID 29278410 https://doi.org/10.1002/14651858.CD006250.pub2

2017-11 Medical and dietary interventions for preventing recurrent urinary stones in children PMID 29117629 https://doi.org/10.1002/14651858.CD011252.pub2

2017-11 Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia PMID 29161773 https://doi.org/10.1002/14651858.CD012615.pub2

2017-10 Desmopressin for treating nocturia in men PMID 29055129 https://doi.org/10.1002/14651858.CD012059.pub2

2017-9 Intravesical electromotive drug administration for non-muscle invasive bladder cancer PMID 28898400 https://doi.org/10.1002/14651858.CD011864.pub2

2017-5 Immunotherapy for metastatic renal cell carcinoma PMID 28504837 https://doi.org/10.1002/14651858.CD011673.pub2

2017-5 Partial nephrectomy versus radical nephrectomy for clinical localised renal masses PMID 28485814 https://doi.org/10.1002/14651858.CD012045.pub2

2017-5 Alvimopan for recovery of bowel function after radical cystectomy PMID 28462518 https://doi.org/10.1002/14651858.CD012111.pub2

2017-3 Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer PMID 28268259 https://doi.org/10.1002/14651858.CD012112.pub2

2016-7 Surgery versus non-surgical management for unilateral ureteric-pelvic junction obstruction in newborns and infants less than two years of age PMID 27416073 https://doi.org/10.1002/14651858.CD010716.pub2

2014-6 Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer PMID 24979481 https://doi.org/10.1002/14651858.CD009266.pub2

2014-2 Dietary interventions for preventing complications in idiopathic hypercalciuria PMID 24519664 https://doi.org/10.1002/14651858.CD006022.pub4

2013-12 Percussion, diuresis, and inversion therapy for the passage of lower pole kidney stones following shock wave lithotripsy PMID 24318643 https://doi.org/10.1002/14651858.CD008569.pub2

2013-12 Psychosocial interventions for men with prostate cancer PMID 24368598 https://doi.org/10.1002/14651858.CD008529.pub3

2013-8 Antimicrobial therapy for chronic bacterial prostatitis PMID 23934982 https://doi.org/10.1002/14651858.CD009071.pub2

2012-8 Pregabalin for chronic prostatitis PMID 22895982 https://doi.org/10.1002/14651858.CD009063.pub2

2012-5 Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi PMID 22592707 https://doi.org/10.1002/14651858.CD006029.pub4

2012-2 Fluids and diuretics for acute ureteric colic PMID 22336806 https://doi.org/10.1002/14651858.CD004926.pub3

2011-12 Adjuvant radiotherapy following radical prostatectomy for prostate cancer PMID 22161411 https://doi.org/10.1002/14651858.CD007234.pub2

2011-11 Lycopene for the prevention of prostate cancer PMID 22071840 https://doi.org/10.1002/14651858.CD008007.pub2

2011-8 Psychosocial interventions for premature ejaculation PMID 21833964 https://doi.org/10.1002/14651858.CD008195.pub2

2011-7 Low-dose rate brachytherapy for men with localized prostate cancer PMID 21735436 https://doi.org/10.1002/14651858.CD008871.pub2

2011-5 Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer PMID 21563157 https://doi.org/10.1002/14651858.CD006885.pub2

2011-4 Gemcitabine for unresectable, locally advanced or metastatic bladder cancer PMID 21491413 https://doi.org/10.1002/14651858.CD008976.pub2

2011-4 Surgical management for upper urinary tract transitional cell carcinoma PMID 21491399 https://doi.org/10.1002/14651858.CD007349.pub2